Ondansetron Injection
Product Images NDC 16729-298

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 16729-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2 mg/mL Vial Carton)

Ondansetron Injection USP 40 mg/20 mL (2 mg/mL) multidose vial label by Accord Healthcare, Inc. Intended for intravenous or intramuscular injection, sterile. Label lists active ingredient concentration, directions for use, storage conditions, manufacturing information, and preservatives. NDC 16729-298.*

FDA Label Image

Principal Display Panel (2 mg/mL Vial Label)

Ondansetron Injection USP 40 mg/20 mL (2 mg/mL) sterile injection for intravenous or intramuscular use in a 20 mL multidose vial. The label from Accord Healthcare, Inc. includes active ingredient information, storage instructions, barcode, and regulatory details.*

FDA Label Image

Ondansetron Chemical Structure (Ondansetron Structure)

Chemical structure diagram of ondansetron hydrochloride dihydrate showing its molecular framework including an indole group, a ketone, methyl groups, and imidazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.